Edesa Biotech (NASDAQ:EDSA) | WebDisclosure

Basculer en Français

8201	Companies
109005	Keywords
51275	Articles
60079	Press releases

Home
Companies
Edesa Biotech

BRIEF

published on 06/24/2024 at 14:25, 4 months 8 days ago

BARDA sélectionne le médicament d'Edesa Biotech pour un essai sur plateforme financé par les États-Unis dans le SDRA général

Essai Clinique Edesa Biotechnologie SDRA BARDA Paridiprubart
BRIEF

published on 06/24/2024 at 14:25, 4 months 8 days ago

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

Clinical Trial Edesa Biotech ARDS BARDA Paridiprubart
PRESS RELEASE

published on 06/24/2024 at 14:20, 4 months 8 days ago

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS
Edesa Biotech's paridiprubart selected for BARDA-funded Phase 2 trial to evaluate treatment for ARDS in hospitalized patients. Study to focus on threat-agnostic host-directed therapeutics

Edesa Biotech ARDS Phase 2 Trial Paridiprubart BARDA-funded
BRIEF

published on 05/10/2024 at 22:20, 5 months 23 days ago

Edesa Biotech publie ses résultats du 2e trimestre de l'exercice 2024

Performance Financière Edesa Biotechnologie Études Cliniques Résultats Trimestriels Fiscaux Traitement Du SDRA
BRIEF

published on 05/10/2024 at 22:20, 5 months 23 days ago

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

Financial Performance Edesa Biotech Clinical Studies Fiscal Quarterly Results ARDS Treatment
PRESS RELEASE

published on 05/10/2024 at 22:15, 5 months 23 days ago

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Edesa Biotech, Inc. reported financial results for the three and six months ended March 31, 2024, focusing on its Phase 3 ARDS study, EB05 drug candidate, and strategic plans for respiratory technology and dermatology. The company showcased operational efficiency and prudent capital management

Financial Results Edesa Biotech Inc Phase 3 ARDS Study EB05 Drug Candidate Respiratory Technology
BRIEF

published on 04/11/2024 at 15:05, 6 months 21 days ago

Edesa Biotech confirme sa participation à la conférence des investisseurs Bloom Burton Healthcare 2024

Biopharmaceutique Essais Cliniques Conférence Sur Les Soins De Santé Edesa Biotechnologie Maladies Immuno-inflammatoires
BRIEF

published on 04/11/2024 at 15:05, 6 months 21 days ago

Edesa Biotech Confirms Participation in 2024 Bloom Burton Healthcare Investor Conference

Immuno-inflammatory Diseases Clinical Trials Biopharmaceutical Edesa Biotech Healthcare Conference
PRESS RELEASE

published on 04/11/2024 at 15:00, 6 months 21 days ago

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Edesa Biotech, Inc. (NASDAQ:EDSA) to participate in Bloom Burton & Co. Healthcare Investor Conference, with CEO Par Nijhawan presenting. Company focuses on host-directed therapeutics for immuno-inflammatory diseases

Immuno-inflammatory Diseases EB05 Edesa Biotech NASDAQ:EDSA Bloom Burton & Co. Healthcare Investor Conference
BRIEF

published on 04/02/2024 at 15:05, 7 months ago

Edesa Biotech participera aux prochaines conférences d'investisseurs

Immunothérapie Essais Cliniques Produits Biopharmaceutiques Edesa Biotechnologie Conférences Investisseurs

1 2 ... 5

Accesswire

Published on 11/03/2024 at 00:45, 12 hours 31 minutes ago

Holtway Global Hedge Expands into Europe, Providing Exclusive Pre-IPO and IPO Access to Companies Led by Visionary Founders like Elon Musk and Sam Altman
Published on 11/02/2024 at 19:15, 18 hours 1 minute ago

Hank Payments Announces Closing of Financing and Settlements
Published on 11/02/2024 at 16:10, 21 hours 6 minutes ago

Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses
Published on 11/02/2024 at 14:30, 22 hours 46 minutes ago

Spa Sciences Health Introduces Revolutionary Nasal Irrigation System at CVS
Published on 11/02/2024 at 00:48, 1 day 12 hours ago

OneSoft Solutions Inc. Announces the Completion of Its Acquisition by Irth Solutions LLC, a Blackstone Portfolio Company

View all ACCESSWIRE

EQS Group

Published on 11/01/2024 at 21:31, 1 day 15 hours ago

Original-Research: Telefonica Deutschland Holding AG (von First Berlin Equity Research GmbH): Buy
Published on 11/01/2024 at 18:18, 1 day 18 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/01/2024 at 17:47, 1 day 19 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/01/2024 at 17:10, 1 day 20 hours ago

EQS-Adhoc: fox e-mobility AG: provisional debt restructuring moratorium of Fox Automotive Switzerland AG
Published on 11/01/2024 at 16:00, 1 day 21 hours ago

Total Voting Rights

Les Echos

Published on 10/31/2024 at 20:26, 2 days 16 hours ago

I.CERAM - Résultat du 1er semestre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Déclaration hebdomadaire d'opérations effectuées du 28 au 31 octobre 2024
Published on 10/31/2024 at 18:19, 2 days 18 hours ago

Disclosure of transactions in own shares on October 28 to October 31, 2024
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION : CHIFFRE D’AFFAIRES TROISIEME TRIMESTRE 2024 : +3%
Published on 10/31/2024 at 18:00, 2 days 19 hours ago

GUILLEMOT CORPORATION: THIRD QUARTER 2024 TURNOVER UP 3%

View all LES ECHOS COMFI WIRE